Aurinia Pharmaceuticals Inc AUPH
$15.47
+1.91%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 4 | FORM 4 | 2026-06-08 | View → |
| 8-K | 8-K | 2026-06-04 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | FORM 4 | 2026-05-20 | View → |
| 4 | FORM 4 | 2026-05-20 | View → |
| 4 | FORM 4 | 2026-05-20 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-21 | View → |
| 8-K | 8-K | 2026-04-03 | View → |
| 8-K | 8-K | 2026-03-23 | View → |
| 4 | FORM 4 | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 4 | FORM 4 | 2026-03-03 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
| 4 | FORM 4 | 2026-02-23 | View → |
| 4 | FORM 4 | 2026-02-23 | View → |
| 4 | FORM 4 | 2026-02-23 | View → |
| 4 | FORM 4 | 2026-02-23 | View → |
| 4 | FORM 4 | 2026-02-03 | View → |
| 4 | FORM 4 | 2026-01-05 | View → |
| 4 | FORM 4 | 2026-01-05 | View → |
| 4 | FORM 4 | 2026-01-05 | View → |
| 4 | FORM 4 | 2026-01-05 | View → |
| 4 | FORM 4 | 2025-11-24 | View → |
| 4 | FORM 4 | 2025-11-24 | View → |
| 8-K | 8-K | 2025-11-04 | View → |
| 10-Q | 10-Q | 2025-11-04 | View → |
| 4 | Insider transaction | 2025-08-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $15.47
- Market Cap
- $2.06 billion
- 52-Week Range
- $8.28 – $19.25
- Average Volume
- 1.23 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.